{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:25:44Z","timestamp":1789885544185,"version":"4.0.1"},"reference-count":71,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["HOP-134065"],"award-info":[{"award-number":["HOP-134065"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>The dependence of adenovirus on the host pre-RNA splicing machinery for expression of its complete genome potentially makes it vulnerable to modulators of RNA splicing, such as digoxin and digitoxin. Both drugs reduced the yields of four human adenoviruses (HAdV-A31, -B35, and -C5 and a species D conjunctivitis isolate) by at least 2 to 3 logs by affecting one or more steps needed for genome replication. Immediate early E1A protein levels are unaffected by the drugs, but synthesis of the delayed protein E4orf6 and the major late capsid protein hexon is compromised. Quantitative reverse transcription-PCR (qRT-PCR) analyses revealed that both drugs altered E1A RNA splicing (favoring the production of 13S over 12S RNA) early in infection and partially blocked the transition from 12S and 13S to 9S RNA at late stages of virus replication. Expression of multiple late viral protein mRNAs was lost in the presence of either drug, consistent with the observed block in viral DNA replication. The antiviral effect was dependent on the continued presence of the drug and was rapidly reversible. RIDK34, a derivative of convallotoxin, although having more potent antiviral activity, did not show an improved selectivity index. All three drugs reduced metabolic activity to some degree without evidence of cell death. By blocking adenovirus replication at one or more steps beyond the onset of E1A expression and prior to genome replication, digoxin and digitoxin show potential as antiviral agents for treatment of serious adenovirus infections. Furthermore, understanding the mechanism(s) by which digoxin and digitoxin inhibit adenovirus replication will guide the development of novel antiviral therapies.<\/jats:p>\n          <jats:p>\n            <jats:bold>IMPORTANCE<\/jats:bold>\n            Despite human adenoviruses being a common and, in some instances, life-threating pathogen in humans, there are few well-tolerated therapies. In this report, we demonstrate that two cardiotonic steroids already in use in humans, digoxin and digitoxin, are potent inhibitors of multiple adenovirus species. A synthetic derivative of the cardiotonic steroid convallotoxin was even more potent than digoxin and digitoxin when tested with HAdV-C5. These drugs alter the cascade of adenovirus gene expression, acting after initiation of early gene expression to block viral DNA replication and synthesis of viral structural proteins. These findings validate a novel approach to treating adenovirus infections through the modulation of host cell processes.\n          <\/jats:p>","DOI":"10.1128\/jvi.01623-16","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T03:00:48Z","timestamp":1479956448000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":55,"title":["Suppression of Adenovirus Replication by Cardiotonic Steroids"],"prefix":"10.1128","volume":"91","author":[{"given":"Filomena","family":"Grosso","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stoilov","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of West Virginia Medical School, Morgantown, West Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Lingwood","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cochrane","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"1732","volume-title":"Fields virology","author":"Wold WSM","year":"2013","unstructured":"Wold WSM Ison MG . 2013. Adenoviruses, p 1732\u20131767. InKnipeDMHowleyPM (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA, USA.","edition":"6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.000196"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197507032930118"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-259291"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00116-13"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.03.027"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1877"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.01.005"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki057"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.1010-1016.2005"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(85)90123-3"},{"key":"e_1_3_2_13_2","first-page":"3","article-title":"Digoxin 1785-1985. I. Two hundred years of digitalis","volume":"11","author":"Wade OL","year":"1986","unstructured":"Wade OL . 1986. Digoxin 1785-1985. I. Two hundred years of digitalis. J Clin Hosp Pharm11:3\u20139.","journal-title":"J Clin Hosp Pharm"},{"key":"e_1_3_2_14_2","volume-title":"An account of the foxglove and some of its medical uses with practical remarks on dropsy and other diseases","author":"Withering W","year":"1785","unstructured":"Withering W . 1785. An account of the foxglove and some of its medical uses with practical remarks on dropsy and other diseases. Birmingham, London, United Kingdom."},{"key":"e_1_3_2_15_2","volume-title":"The natural history of Pliny, 1856 ed","author":"Pliny the Elder","unstructured":"Pliny the Elder. 77. The squill: twenty-three remedies. InBostockJRileyHT (ed), The natural history of Pliny, 1856 ed. G. Bell & Sons, London, United Kingdom."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2682"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0421"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1124\/mi.8.1.8"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2012.690033"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-006-0824-x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.9.1265"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00098.2007"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00707.2004"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.12.1441"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002950200"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152907781745288"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00179"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1124\/mi.3.3.157"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00412-013-0407-z"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801661105"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1261\/rna.032912.112"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003241"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt471"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.8.3171"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(77)90180-5"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19497-0"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16022893"},{"key":"e_1_3_2_38_2","first-page":"1704","volume-title":"Fields virology","author":"Berk AJ","year":"2013","unstructured":"Berk AJ . 2013. Adenoviridae, p 1704\u20131731. InKnipeDMHowleyPM (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA, USA.","edition":"6"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2014.04.006"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(80)90362-1"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.2741\/3059"},{"key":"e_1_3_2_42_2","first-page":"794","article-title":"Titration of serine\/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing","volume":"1","author":"Himmelspach M","year":"1995","unstructured":"Himmelspach M Cavaloc Y Chebli K Stevenin J Gattoni R . 1995. Titration of serine\/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing. RNA1:794\u2013806.","journal-title":"RNA"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(79)90036-6"},{"key":"e_1_3_2_44_2","unstructured":"De Gouveia\nP\n. 2010. Cardiac glycosides a novel treatment for neuroblastoma: efficacy and mechanism. M.Sc. thesis. University of Toronto Toronto Ontario Canada."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(91)90322-3"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/v5123192"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-396456-4.00002-X"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01463-15"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12053"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12387"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90382-Z"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152692"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00074-10"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002549"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.4.864"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/30277"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20081501"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1042\/BST0330443"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.6.5.837"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.19.9002-9009.2000"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2003.tb05445.x"},{"key":"e_1_3_2_62_2","first-page":"410","volume-title":"Applied pharmokinetics and pharmacodynamics","author":"Schentag J","year":"2006","unstructured":"Schentag J Bang A Kozinski-Tober J . 2006. Principles of therapeutic drug monitoring, p 410. InBurtonMShawLSchentagJEvansW (ed), Applied pharmokinetics and pharmacodynamics. Lippincott Williams & Wilkins, Philadelphia, PA, USA."},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197702010-00002"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.05.001"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00693-16"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-36-1-59"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0995fje"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.22.2.205-209.1985"},{"key":"e_1_3_2_69_2","first-page":"493","article-title":"A simple method of estimating fifty percent end-points","volume":"27","author":"Reed LJ","year":"1938","unstructured":"Reed LJ Muench H . 1938. A simple method of estimating fifty percent end-points. Am J Hyg (Lond)27:493\u2013497.","journal-title":"Am J Hyg (Lond)"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh593"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2008.01163.x"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2009.6"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01623-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01623-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T14:26:44Z","timestamp":1646490404000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01623-16"}},"subtitle":[],"editor":[{"given":"Grant","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1128\/JVI.01623-16"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01623-16","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"2016-08-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01623-16"}}